NO932129L - Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater - Google Patents

Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater

Info

Publication number
NO932129L
NO932129L NO932129A NO932129A NO932129L NO 932129 L NO932129 L NO 932129L NO 932129 A NO932129 A NO 932129A NO 932129 A NO932129 A NO 932129A NO 932129 L NO932129 L NO 932129L
Authority
NO
Norway
Prior art keywords
chain
lower alkyl
single bond
heteroaryl
procedure
Prior art date
Application number
NO932129A
Other languages
English (en)
Norwegian (no)
Other versions
NO932129D0 (no
Inventor
Dieter Binder
Josef Weinberger
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of NO932129D0 publication Critical patent/NO932129D0/no
Publication of NO932129L publication Critical patent/NO932129L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO932129A 1992-07-03 1993-06-10 Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater NO932129L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0136092A AT399880B (de) 1992-07-03 1992-07-03 Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
NO932129D0 NO932129D0 (no) 1993-06-10
NO932129L true NO932129L (no) 1994-01-04

Family

ID=3512206

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932129A NO932129L (no) 1992-07-03 1993-06-10 Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater

Country Status (23)

Country Link
US (1) US5527796A (lt)
EP (1) EP0576906A1 (lt)
JP (1) JPH06157543A (lt)
KR (1) KR940005638A (lt)
CN (1) CN1083066A (lt)
AT (1) AT399880B (lt)
AU (1) AU662229B2 (lt)
CA (1) CA2097167A1 (lt)
CZ (1) CZ129693A3 (lt)
EE (1) EE9400148A (lt)
FI (1) FI932863L (lt)
HR (1) HRP931016A2 (lt)
HU (1) HUT68733A (lt)
IL (1) IL105774A (lt)
LT (1) LT3159B (lt)
LV (1) LV10618B (lt)
MD (1) MD940297A (lt)
MY (1) MY109432A (lt)
NO (1) NO932129L (lt)
NZ (1) NZ247690A (lt)
SI (1) SI9300356A (lt)
SK (1) SK63893A3 (lt)
ZA (1) ZA933899B (lt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400845B (de) * 1993-12-06 1996-03-25 Chem Pharm Forsch Gmbh Neue thienothiazinderivate, ein verfahren zu ihrer herstellung und ihre verwendung
EP0658559A1 (de) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
DE4400867A1 (de) * 1994-01-14 1995-07-20 Nycomed Arzneimittel Gmbh Neue Thienothiazinderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
WO1999065897A1 (en) 1998-06-19 1999-12-23 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US6297260B1 (en) * 1998-10-30 2001-10-02 Nitromed, Inc. Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
CN1171892C (zh) * 2001-06-25 2004-10-20 李晶 具有抗炎镇痛活性的噻吩并噻嗪化合物及其制备方法和用途
CN111646987B (zh) * 2020-06-05 2022-06-24 湖南师范大学 一种5-氨基噻唑类非甾体抗炎化合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
MC1135A1 (fr) * 1976-02-23 1977-11-18 Hoffmann La Roche Derives de thiazine
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE3371082D1 (de) * 1982-09-09 1987-05-27 Hoffmann La Roche Thieno(2,3-e)-1,2-thiazine derivatives
NZ226477A (en) * 1987-10-29 1990-07-26 Cl Pharma Substituted thieno (2,3-e)-1,2 thiazine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
NZ247690A (en) 1994-12-22
MY109432A (en) 1997-01-31
EP0576906A1 (de) 1994-01-05
ATA136092A (de) 1994-12-15
LV10618A (lv) 1995-04-20
CZ129693A3 (en) 1994-01-19
AU4172693A (en) 1994-01-06
ZA933899B (en) 1994-06-14
JPH06157543A (ja) 1994-06-03
LT3159B (en) 1995-01-31
LV10618B (en) 1996-06-20
LTIP760A (en) 1994-05-15
CN1083066A (zh) 1994-03-02
FI932863A7 (fi) 1994-01-04
FI932863A0 (fi) 1993-06-21
HU9301920D0 (en) 1993-09-28
KR940005638A (ko) 1994-03-22
EE9400148A (et) 1995-12-15
AT399880B (de) 1995-08-25
SI9300356A (en) 1994-03-31
CA2097167A1 (en) 1994-01-04
MD940297A (ro) 1996-02-29
FI932863L (fi) 1994-01-04
SK63893A3 (en) 1994-02-02
HUT68733A (en) 1995-07-28
IL105774A0 (en) 1993-09-22
US5527796A (en) 1996-06-18
IL105774A (en) 1997-01-10
AU662229B2 (en) 1995-08-24
HRP931016A2 (en) 1997-04-30
NO932129D0 (no) 1993-06-10

Similar Documents

Publication Publication Date Title
NO944700L (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
MY107756A (en) Piperazine derivatives.
TWI224595B (en) New benzazepine derivatives, drugs containing these and use of the same for producing drugs
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
IE781878L (en) Imidazole derivatives
NO932129L (no) Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater
NZ511067A (en) Serine protease inhibiting isoquinoline derivatives and their use for treating or preventing thrombin-mediated or thrombin-associated diseases
GR3024430T3 (en) Piperazine derivatives as 5-ht antagonists.
EP0144986A3 (en) Indole-3-carboxamide derivatives
DK129282A (da) Fremgangsmaade til fremstilling af indolylethylderivater
SE8802790L (sv) Tripeptider med immunostimulerande och metastasfoerhindrande verkan
WO1994020459A3 (en) Pyrrolo-pyridine derivatives as dopamine receptor ligands
IE40570B1 (en) Benzylamine derivatives and process for preparing them
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
CA2048010A1 (en) Proline derivatives
ES8401067A1 (es) Procedimiento analogo para preparar un derivado de tropil benzoato.
AU1065592A (en) Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers
UA21900A (uk) Похідhі глутатіоhу або їх фармацевтичhо прийhятhі солі, які проявляють протизапальhу, протиалергійhу та гепатотропhу активhість, і спосіб їх одержаhhя
WO2000027832A3 (en) Thiazole derivatives as ppar gamma ligands
NO944680L (no) Nye tienotiazinerivater, en fremgangsmåte til fremstilling derav samt deres anvendelse
DK149270C (da) Analogifremgangsmaade til fremstilling af beta-carbolin-3-carboxylsyrederivater
GB1399470A (en) Derivatives of pyrazolopyridine ketones
NO953557L (no) Antitumorpreparater og fremgangsmåte for deres fremstilling
ES8604843A1 (es) Un metodo para la preparacion de un derivado de acetileno
NZ291855A (en) Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists